These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28900490)

  • 1. Wnt3a Expression Is Associated with Epithelial-Mesenchymal Transition and Impacts Prognosis of Lung Adenocarcinoma Patients.
    Xu J; Lv W; Hu Y; Wang L; Wang Y; Cao J; Hu J
    J Cancer; 2017; 8(13):2523-2531. PubMed ID: 28900490
    [No Abstract]   [Full Text] [Related]  

  • 2. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
    Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
    J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAP4 acts as an oncogene and prognostic marker and affects radioresistance by mediating epithelial-mesenchymal transition in lung adenocarcinoma.
    Xia X; Ge Y; Ge F; Gu P; Liu Y; Li P; Xu P
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):88. PubMed ID: 38341398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
    Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
    Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between the Immunohistochemistry Expression of E-cadherin, Beta-Catenin, and CD44 in Colorectal Adenocarcinoma.
    Tunuguntla A; Suresh TN; Pn S
    Cureus; 2023 Mar; 15(3):e35686. PubMed ID: 37012965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the E-Cadherin/β-Catenin Complex Is an Independent Poor Prognostic Factor in Lung Adenocarcinoma.
    Kim H; Yoo SB; Sun P; Jin Y; Jheon S; Lee CT; Chung JH
    Korean J Pathol; 2013 Feb; 47(1):44-51. PubMed ID: 23483484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of SPP1 as a promising biomarker to predict clinical outcome of lung adenocarcinoma individuals.
    Li S; Yang R; Sun X; Miao S; Lu T; Wang Y; Wo Y; Jiao W
    Gene; 2018 Dec; 679():398-404. PubMed ID: 30240883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT.
    Wang J; Cai H; Liu Q; Xia Y; Xing L; Zuo Q; Zhang Y; Chen C; Xu K; Yin P; Chen T
    Am J Chin Med; 2020; 48(3):703-718. PubMed ID: 32329642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
    Prins MJ; Ruurda JP; Lolkema MP; Sitarz R; Ten Kate FJ; van Hillegersberg R
    J Clin Pathol; 2015 Jul; 68(7):529-35. PubMed ID: 25855799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Prognostic Significance of the Epithelial-Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity Score-Matched Analysis.
    Matsubara T; Tagawa T; Takada K; Toyokawa G; Shimokawa M; Kozuma Y; Akamine T; Haro A; Osoegawa A; Mori M
    Clin Lung Cancer; 2019 Jul; 20(4):e504-e513. PubMed ID: 31103348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
    Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
    Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
    da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
    Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
    Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
    Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EMT status in the primary tumor does not predict postoperative recurrence or disease-free survival in lung adenocarcinoma.
    Chikaishi Y; Uramoto H; Tanaka F
    Anticancer Res; 2011 Dec; 31(12):4451-6. PubMed ID: 22199314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of epithelial-mesenchymal transition markers E-cadherin, N-cadherin, β-catenin and ZEB2 in laryngeal squamous cell carcinoma.
    Zhu GJ; Song PP; Zhou H; Shen XH; Wang JG; Ma XF; Gu YJ; Liu DD; Feng AN; Qian XY; Gao X
    Oncol Lett; 2018 Mar; 15(3):3472-3481. PubMed ID: 29467869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
    Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
    Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of Stathmin1 expression and epithelial-mesenchymal transition in curatively resected gastric cancer.
    Ke B; Guo XF; Li N; Wu LL; Li B; Zhang RP; Liang H
    Mol Clin Oncol; 2019 Feb; 10(2):214-222. PubMed ID: 30680197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
    Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M
    PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
    Mitselou A; Galani V; Skoufi U; Arvanitis DL; Lampri E; Ioachim E
    Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.